Opioid Pharmacology and Use

Opioids are analgesics that act on opioid receptors to relieve moderate to severe pain. They are among the most effective drugs for acute and cancer pain but carry distinctive risks - respiratory depression, tolerance, physical dependence, and the potential for misuse - that make their pharmacology and rational use a central topic in pain medicine.

Definition

Opioids are analgesic drugs that bind opioid receptors - principally the mu receptor - to inhibit nociceptive transmission and produce analgesia, along with characteristic effects such as respiratory depression, sedation, and the potential for tolerance and dependence.

Scope

The entry covers the opioid receptor system and the mechanism of opioid analgesia, the main pharmacological properties of opioid drugs (potency, agonist and partial-agonist activity), and the principal adverse effects and risks including respiratory depression, tolerance, dependence, and opioid use disorder. It frames these as pharmacological and methodological topics and links to contemporary prescribing guidance without itself giving dosing or treatment advice.

Core questions

• How does activation of opioid receptors, especially the mu receptor, produce analgesia?
• What distinguishes full agonists, partial agonists, and mixed agonist-antagonists pharmacologically?
• Why do tolerance, physical dependence, and the risk of opioid use disorder arise, and how do they differ from one another?
• What is opioid-induced respiratory depression and why is it the principal acute danger of these drugs?

Key concepts

• Opioid receptors (mu, kappa, delta)
• Full agonist versus partial agonist versus mixed agonist-antagonist
• Descending inhibitory modulation
• Tolerance and opioid-induced hyperalgesia
• Physical dependence and withdrawal
• Opioid use disorder and misuse
• Respiratory depression and naloxone reversal

Mechanisms

Opioids bind G-protein-coupled opioid receptors - mu, kappa, and delta - located along the pain pathway in the spinal cord dorsal horn, brainstem, and higher centres, as well as peripherally. Receptor activation reduces neuronal excitability and neurotransmitter release and engages descending inhibitory pathways, dampening the transmission and perception of pain. The same mu-receptor activation in the brainstem respiratory centres depresses ventilation, the principal acute danger of opioids, which can be reversed by the antagonist naloxone. Repeated exposure produces tolerance (diminished effect at a given dose) and physical dependence (a withdrawal syndrome on cessation); these neuroadaptations are distinct from opioid use disorder, the compulsive misuse pattern. Opioids differ in potency, receptor activity, and pharmacokinetics, which shapes their analgesic and safety profiles.

Clinical relevance

Opioids remain important for acute and cancer pain and for selected other states, and understanding their pharmacology and risks is central to appraising the evidence and guidelines that govern their use. This entry describes opioid pharmacology and the rationale of cautious use; it is a reference resource and does not provide dosing, conversion, or individualised prescribing recommendations.

Epidemiology

Opioid prescribing rose substantially in the late twentieth and early twenty-first centuries and was followed by marked increases in opioid-related harms, including overdose deaths, prompting major shifts in guidelines toward more cautious use and toward nonopioid and multimodal alternatives. The balance between ensuring access for those who benefit and limiting harm is a defining public-health tension of the field.

History

Opium has been used for pain since antiquity, and the isolation of morphine in the early nineteenth century gave a purified, dosable opioid. Semi-synthetic and synthetic opioids followed, and the identification of opioid receptors and endogenous opioid peptides in the 1970s explained their mechanism. Liberalised prescribing for chronic non-cancer pain in the 1990s and 2000s, and the subsequent recognition of widespread harm, drove the contemporary re-evaluation reflected in current guidelines.

Debates

Should opioids be used for chronic non-cancer pain?

Evidence for durable benefit of long-term opioid therapy in chronic non-cancer pain is limited while the risks of dependence, hyperalgesia, and misuse are well documented, so contemporary guidance restricts such use in favour of nonopioid and multimodal approaches.

Seminal works

• ballantyne-2003
• dahan-2010
• dowell-2022

Frequently asked questions

What is the most dangerous acute effect of opioids?

Respiratory depression: opioids acting on brainstem respiratory centres can slow or stop breathing, which is the principal acute cause of opioid-related death and can be reversed by the antagonist naloxone.

Are tolerance and dependence the same as addiction?

No. Tolerance (reduced effect over time) and physical dependence (withdrawal on stopping) are expected physiological adaptations to continued opioid exposure, whereas opioid use disorder is a distinct condition defined by compulsive use and loss of control.